These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11582578)

  • 1. An algorithm for evaluating the ethics of a placebo-controlled trial.
    Amdur RJ; Biddle CJ
    Int J Cancer; 2001 Oct; 96(5):261-9. PubMed ID: 11582578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ethics of placebo-controlled trials: a comparison of inert and active placebo controls.
    Edward SJ; Stevens AJ; Braunholtz DA; Lilford RJ; Swift T
    World J Surg; 2005 May; 29(5):610-4. PubMed ID: 15827854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical issues in studies in Thailand of the vertical transmission of HIV.
    Phanuphak P
    N Engl J Med; 1998 Mar; 338(12):834-5. PubMed ID: 9504948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebos in clinical trials of peptic ulcer. ACG Committee on FDA-Related Matters.
    Smith JL
    Am J Gastroenterol; 1989 May; 84(5):469-74. PubMed ID: 2719003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
    Daugherty CK; Ratain MJ; Emanuel EJ; Farrell AT; Schilsky RL
    J Clin Oncol; 2008 Mar; 26(8):1371-8. PubMed ID: 18227527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ethics of placebo-controlled trials: the case of asthma.
    Onder RF
    J Allergy Clin Immunol; 2005 Jun; 115(6):1228-34. PubMed ID: 15940139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo in clinical drug trials--a multidisciplinary review.
    Haegerstam G; Huitfeldt B; Nilsson BS; Sjövall J; Syvälahti E; Wahlén A
    Methods Find Exp Clin Pharmacol; 1982; 4(4):261-78. PubMed ID: 6750286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the use of placebo controls in clinical trials of psychopharmacologic agents. Loma Linda University Institutional Review Board.
    Orr RD
    Psychiatr Serv; 1996 Nov; 47(11):1262-4. PubMed ID: 8916249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebos and paradoxes in psychiatric research: an ethics perspective.
    Roberts LW; Lauriello J; Geppert C; Keith SJ
    Biol Psychiatry; 2001 Jun; 49(11):887-93. PubMed ID: 11377406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials: specific problems associated with the use of a placebo-control group.
    Cleophas TJ
    J Mol Med (Berl); 1995 Aug; 73(8):421-4. PubMed ID: 8528745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ethical and legal aspects of the use of placebos in research and practice].
    Blanz M
    Fortschr Neurol Psychiatr; 1990 May; 58(5):167-74. PubMed ID: 2191911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making moral decisions on a double-blinded drug trial in progress without breaking the code: a primer on posterior analysis.
    Allen AD
    Med Decis Making; 1989; 9(3):207-16. PubMed ID: 2668682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethics of randomized clinical trials.
    Rosner F
    Am J Med; 1987 Feb; 82(2):283-90. PubMed ID: 3812521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases.
    Ellenberg SS; Temple R
    Ann Intern Med; 2000 Sep; 133(6):464-70. PubMed ID: 10975965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo-controlled trials and the Declaration of Helsinki.
    Lewis JA; Jonsson B; Kreutz G; Sampaio C; van Zwieten-Boot B
    Lancet; 2002 Apr; 359(9314):1337-40. PubMed ID: 11965296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can placebo controls reduce the number of nonresponders in clinical trials? A power-analytic perspective.
    Leon AC
    Clin Ther; 2001 Apr; 23(4):596-603. PubMed ID: 11354393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward rapproachment in the placebo control debate. A calculated compromise of power.
    Leon AC; Solomon DA
    Eval Health Prof; 2003 Dec; 26(4):404-14. PubMed ID: 14631611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical issues related to the use of placebo in clinical trials.
    Lau JT; Mao J; Woo J
    Hong Kong Med J; 2003 Jun; 9(3):192-8. PubMed ID: 12777655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.
    Polman CH; Reingold SC; Barkhof F; Calabresi PA; Clanet M; Cohen JA; Cutter GR; Freedman MS; Kappos L; Lublin FD; McFarland HF; Metz LM; Miller AE; Montalban X; O'Connor PW; Panitch H; Richert JR; Petkau J; Schwid SR; Sormani MP; Thompson AJ; Weinshenker BG; Wolinsky JS
    Neurology; 2008 Mar; 70(13 Pt 2):1134-40. PubMed ID: 18362273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials: specific problems associated with the use of a placebo control group.
    Cleophas TJ; vd Meulen J; Kalmansohn RB
    Br J Clin Pharmacol; 1997 Mar; 43(3):219-21. PubMed ID: 9088576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.